However, analyzing the subpopulations of CD4+ T cells in more depth, recolonization reversed the increase in both Foxp3+CD39+ T cells and Foxp3−CD39+ T cells induced by ABX treatment in TMEV infected mice, supporting the beneficial role of CD39+ Treg cells in preventing MS progression. The gene discussed is CD4; the disease is myeloid sarcoma.